Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Download PDF
May 3, 2016
/
News
Share
the Post
Related
Posts
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015
Part 2: How is hepatitis C treated?
Part 1: What is hepatitis C and how is it diagnosed?
Pricing of Indian generic sofosbuvir, 30th Jan,2016
Community group taking actions to enable greater access for generic HCV treatment
Hepatitis C Treatment Snapshots: ledipasvir and sofosbuvir co-formulation
A two pager of what you need to know of Sofosbuvir
